Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study.

However, when stratified by hospitalization, the relative risk ratio of requiring tocilizumab failed to reach significance between two groups (RR 0.49, p = 0.152, CI 0.17–1.31) ( Table 2 ; Figure 2) . 3.2.3 Days in hospital The mean hospital stay for hospitalized patients was 8.3 days (median 6 days).

also in 4,113 other papers